第52回高血圧関連疾患モデル学会学術総会のご案内

第52回高血圧関連疾患モデル学会学術総会のご案内
ポスターミニシンポのご案内
第52回高血圧関連疾患モデル学会では、第17回国際SHRシンポジウムで掲示された国内からのポスタ
ーを、9月23日㈮の午後にポスターミニシンポとして発表者、モデュレーター、コメンテーターでデ
ィスカッションを行います。
1．発表日時
日付
9月23日㈮
時間
セッション名
P１－１～９
14:00-16:00各セッション、 P２－１～10
同時スタートとなります。 P３－１～３、７～９、11～13
P４－１～５、７～９
2．発表時間：発表7分、質疑3分
3．会場：秋葉原UDX　4F　UDXギャラリー　ポスター会場
4．モデュレーターの皆様へ：発表の進行、討論の盛り上げ役をお願い致します。研究内容に関する
質疑応答や相互討論の他、研究手法、結果の解釈、将来展開など様々な角度からディスカッショ
ンしていただき、研究テーマを掘り下げるなどして下さい。
5．コメンテーターの皆様へ：各演題発表後に、ご専門の立場から質問やコメントをいだだきますよ
うお願い致します。
6．ポスターサイズ・掲示方法は第17回国際SHRシンポジウムと同じで英文のポスター
7．ポスター掲示日時
掲示：2016年9月22日㈭ 9:00−11:00
撤去：2016年9月23日㈮ 16:00−16:30
※撤去時間以降の保管･返却は致しかねますのでご了承下さい。
日本高血圧学会専門医資格更新のための単位取得について
高血圧専門医を取得されている方は、本会の参加で、資格更新のための単位を2単位取得出来ます。
資格更新時に参加証を提出して頂きますので、大切に保管して下さい。
16
ポスターミニシンポ
Poster Presentation (Friday 23 September 14:00-16:00)
1: Genome
P1-1～P1-9
モデュレーター：竹内史比古（国立国際医療研究センター研究所）
コメンテーター：中尾友美（和歌山県立医科大学第二生理学講座）
P1-1
The altered circadian clock inducing glucocorticoid reactivation in SHR.
Sho Tanaka, Division of Nephrology Hypertension and Endocrinology, Department of Medicine, Nihon
University School of Medicine
P1-2
Identification of clock controlled blood pressure regulating genes in the kidney of SHR/Izm
Yusuke Murata, Division of Nephrology, Hypertension and Endocrinology, Department of Internal Medicine,
Nihon University School of Medicine
P1-3
A comparative analysis of the transcriptome and heart function between clock mutant animals
Tomomi Nakao, Departments of Physiology and Pathology, and Radioisotope Laboratory Center, Wakayama
Medical University
P1-4
Further reduction of stroke QTLs on chromosomes 1 and 18 in SHRSP using double subcongenic rats
Kaoru Niiya, Department of Functional Pathology, Shimane University School of Medicine
P1-5
Epigenetic changes in the brain with high-salt intervention in SHR
Hana Shimizu-Furusawa, Department of Gene Diagnostics and Therapeutics, Research Institute, National
Center for Global Health and Medicine
P1-6
Epigenetic changes in the liver with high-fat-diet intervention in SHR
Hana Shimizu-Furusawa, Department of Gene Diagnostics and Therapeutics, Research Institute, National
Center for Global Health and Medicine, Tokyo, Japan
P1-7
Epigenetic changes in the liver with dexamethasone administration in SHR
Hana Shimizu-Furusawa, Department of Gene Diagnostics and Therapeutics, Research Institute, National
Center for Global Health and Medicine, Tokyo, Japan
P1-8
Comparison of epigenetic changes in the liver between Tg-CETP rat and SHR
Hana Shimizu-Furusawa, Department of Gene Diagnostics and Therapeutics, Research Institute, National
Center for Global Health and Medicine, Tokyo, Japan
P1-9
Comparison of epigenetic changes in the liver between RNO4-derived congenic rat and progenitor
strains
Hana Shimizu-Furusawa, Department of Gene Diagnostics and Therapeutics, Research Institute, National
Center for Global Health and Medicine, Tokyo, Japan
17
2: Pathogenesis of Hypertension
P2-1～P2-5
モデュレーター：根岸裕子（武庫川女子大学薬学部）
コメンテーター：青木真美子（近畿大学工学部大学院）
P2-6～P2-10
モデュレーター：大原浩貴（島根大学医学部病理学講座）
コメンテーター：十万佐知子（武庫川女子大学薬学部）
P2-1
The precedence role of metabotropic glutamate receptors in the regulation of baseline blood pressure in
SHRSP
Md Zahid Hasan, Department of Functional Pathology, Shimane University Faculty of Medicine, Shimane,
Japan
P2-2
Oxidative stress and HDAC in the spontaneously hypertensive rats (SHRs)
Mamiko Aoki, Kindai University Graduate School of Systems Engineering, *Kindai University Life Science
Research Institute, Hiroshima
P2-3
Complement 3 induces the salt-sensitive hypertension by induction of dedifferentiation of mesenchymal
tissues with activation of renal RA system in SHR
Eriko Negishi, Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon
University School of Medicine
P2-4
The role of C3 on renin expression during the process of mesenchymal stem cell differentiating into
vascular smooth muscle cell
Lan Chen, Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon
University School of Medicine
P2-5
Role of TWIST-1 on the increased expression of complement 3 in mesenchymal tissues from SHR
Tomoyasu Otsuki, Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon
University School of Medicine
P2-6
The anti-inflammatory effects of hydrogen sulfide in 3T3-L1 adipocytes
Sachiko Juman, School of Pharmacy and Pharmaceutical sciences, Mukogawa Women’s university
P2-7
Difference of taste sensitivity between SHR and WKY
Mohammad Farhadur Reza, Department of Functional Pathology, Shimane University School of Medicine
P2-8
The combination of hypertension and high-fat and -cholesterol diet induces severe hepatic inflammation
in rats via NF-kB and Nrf2 signalings
Yuan Yuan, College of Life and Health Sciences, CHUBU University
P2-9
Novel pathophysiological functions of α-synuclein, causative molecule of Parkinson disease, in vascular
aging and endothelial dysfunction.
Yoichi Takami, Department of Geriatric and General Medicine, Osaka University Graduate School of
Medicine
P2-10
Increased renal AcylCoA Oxidase2 (ACOX2) expression in SHR/Izm
Masahiro Okamura, Division of Nephrology, Hypertension and Endocrinology, Department of Internal
Medicine, Nihon University School of Medicine
18
3: Kidney // Cardiovascular System // Nervous System
P3-1～P3-3
モデュレーター：鷹見洋一（大阪大学大学院医学系研究科老年・腎臓内科学）
コメンテーター：柿添豊（熊本大学大学院生命科学研究部腎臓内科学分野）
P3-7～P3-9
モデュレーター：岸拓弥（九州大学循環器病未来医療研究センター）
コメンテーター：吉川智子（九州大学循環器内科）
P3-11～P3-13
モデュレーター：岸拓弥（九州大学循環器病未来医療研究センター）
コメンテーター：平出幸子（北海道医療大学薬学部）
P3-1
Systematic implantation of dediffarentiated fat cells ameliorated immuno-induced glomerulonephritis
with stimulation of TSG-6
Takashi Maruyama, Division of Nephrology Hypertension and Endocrinology, Department of Medicine,
Nihon University School of Medicine
P3-2
HCaRG is a inhibitor of ErbB receptor-driven tumorigenesis and prognostic for survival in renal cell
carcinoma
Jin Ikeda, Division of General Medicine, Department of Internal Medicine, Nihon University School of
Medicine
P3-3
The role of serine proteases in the regulation of osmotic free water homeostasis.
Yutaka Kakizoe, Department of Nephrology, Kumamoto University Graduate School of Medical Sciences
P3-7
Effect of Angelica acutiloba Kitagawa extract on blood flow regulation in stroke-prone spontaneously
hypertensive rats
Ayaka Kawakami, School of Pharmacy and Pharmaceutical Sciences, Mukogawa Women’s University
P3-8
Apelin-induced blood pressure elevation in mice overexpressing APJ on vascular smooth muscle cells
Chulwon Kwon, Graduate School of Life and Environmental Sciences, Tsukuba Advanced Research Alliance,
University of Tsukuba
P3-9
Disruptive arterial pressure stability is improved by sodium-glucose co-transporter 2 inhibitor in
streptozotocin-induced diabetic rats
Tomoko Yoshikawa, Department of Cardiovascular Medicine, Kyushu University Graduate School of Medical
Sciences
P3-11
N-type Ca Channel in sympathetic nerve terminals and α1A linked Ca channel are contributed to
increased vascular tone but mobilization size from ER is reduced in SHR
Takuzo Hano, Medical Education and Population-based Medicine, Wakayama Medical University
P3-12
Effects of a dopamine re-uptake inhibitor on cortical and accambal dopaminergic system in SHRSP/Ezo
Sachiko Hiraide, Department of Pharmacology, Faculty of Pharmaceutical Science, Health Science University
of Hokkaido
P3-13
Hypertension is a system disruption of dynamic circulatory homeostasis mediated by brain
Takuya Kishi, Collaborative Research Institute of Innovation for Cardiovascular Diseases, Kyushu University
Center for Disruptive Cardiovascular Medicine
19
4: Therapy/Intervention // Experimental Model
P4-1～P4-5
モデュレーター：松田裕之（日本大学医学部総合内科）
コメンテーター：畔上達彦（慶應義塾大学腎臓内分泌代謝内科）
P4-7～P4-9
モデュレーター：北森一哉（金城学院大学生活環境学部）
コメンテーター：松尾裕之（島根大学医学部病態病理学）
P4-1
Intranasal administration of cationic nanogel-based vaccine targeting angiotensin II type 1 receptor
attenuates the development of hypertension in SHR
Tatsuhiko Azegami, Department of Internal Medicine, School of Medicine, Keio University
P4-2
Inhibition of an increase in the blood pressure by food produced by processing residues after fruit juice
extraction in spontaneously hypertensive rats (SHR)
Kohei Kawakami, Department of Experimental Animals, Center for Integrated Research in Science, Shimane
University
P4-3
Drug discovery of a novel gene silencer pyrrole-imidazole polyamide targeting human TGF-β1 for
progressive renal dysfunction
Masari Moriuchi, Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon
University School of Medicine
P4-4
Contribution of TGF-β1 and effects of novel gene silencer PI polyamides to TGF-β1 in diabetic
nephropathy
Shu Horikoshi, Division of Nephrology, Hypertension and Endocrinology, Department of Medicine, Nihon
University School of Medicine
P4-5
Different effect of NEP inhibition with LCZ696 on developing and developed cardiac hypertrophy and
diastolic dysfunction in salt-loaded hypertensive rats.
Go Hamano, Department of Geriatric and General Medicine, Osaka University
P4-7
Increased locomotor activity in congenic SHRSPwch1.0 rats is derived from the increase in systolic
arterial pressure but not the systolic arterial pressure level itself
Hiroshi Kawamura, MGJ Cardiovascular Institute
P4-8
Development of a new rat model for combined hypertension and atherosclerosis; Apoprotein Eknockout SHR
Hiroyuki Matsuo, Department of Functional Pathology, School of Medicine, Shimane University
P4-9
Excitatory synapse dysfunction in the prefrontal cortex of SHRSP/Ezo as an attention deficit/
hyperactivity disorder animal model
Takayuki Senriuchi, Department of Pharmacology, Faculty of Pharmaceutical Sciences, Health Sciences
University of Hokkaido
20

Download Report